Nashua Swim And Tennis Club, Naruto Character Generator Wheel, What Airlines Fly From Cuba To Nicaragua, Door To Door Solicitation Laws In South Carolina, Articles G

GTCR is funded by Blackstone Group. Type: Company - Private. Over the past 31 years, Biocoat has developed a diverse base of both blue-chip and emerging medical device customers, a highly experienced team of engineers and scientists, and state-of-the-art manufacturing and R&D facilities. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. We look forward to supporting Chip, Jim, and the Biocoat team as the Company continues its aggressive pursuit of follow-on acquisitions in the next chapter of its growth.". (if applicable) for The Wall Street Journal. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. GTCR Announces Strategic Investment in Senske Services GTCR Appoints Don McDonough to Lead Business Development for its In total, GTCR has invested in 31 US states and 5 different countries. GTCR Announces Strategic Investment from Blackstone GP Stakes We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. Since 2018, equity firm GTCR has been included on a list of defendants on a long and growing list of personal injury lawsuits related to alleged toxic emissions from the Sterigenics facility in west suburban Willowbrook. On behalf of the Managing Directors of GTCR, Collin Roche and Dean Mihas released a statement: We are thrilled to have this opportunity to work with Blackstone as a passive minority investor in our firm. Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. It has also invested in 2 others. The partnership will provide GTCRs portfolio companies with access to Blackstones group purchasing program, which leverages the buying power of the $150 billion revenue base across Blackstones entire investment platform. Learn more at www.biocoat.com. Since 1980, GTCR has reportedly invested more than $15 billion in over 200 companies. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de Existing Biocoat management and 1315 Capital, the selling equity sponsor, will retain minority stakes in the Company. When typing in this field, a list of search results will appear and be automatically updated as you type. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Individual Investors & Financial Advisors. "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. Contact:Kellie Kennedy312-933-4903kelliek@theharbingergroup.com, View original content to download multimedia:https://www.prnewswire.com/news-releases/gtcr-announces-investment-in-biocoat-301665671.html, Plus500. We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them. Revenue: $500 million to $1 billion (USD) Competitors: Allston Trading, Infinium Capital Management, Rothschild & Co. About. The Company is focused on developing highly technical, customized coating formulations critical to medical device performance.